- American Journal of Bioethics
Here we further analyze the complexity and inherent unfairness of offering COVID-19 drugs via multiple clinical and research pathways. Using remdesivir as an example, we highlight the systemic biases that multiple pathways—both individually and as an overarching system—can engender for vulnerable patients.
- July 14, 2020
Clara Dutari is bilingual, interpreting for Spanish-speaking patients at VCU Health. But she doesn’t just convert words, like a Spanish-English dictionary. She provides context, nuance and intuition to improve communication. One of six interpreters and translators at VCU Medical Center, Dutari sometimes sees patients nodding as their doctor speaks, but she can tell just by looking that the
- April 17, 2020
Infectious diseases physicians at Washington University School of Medicine in St. Louis have developed an expanded access program to give blood plasma from COVID-19 survivors to critically ill patients at Barnes-Jewish Hospital in St. Louis. Led by principal investigator Rachel Presti, MD, PhD, an associate professor of medicine, a team of researchers began enrolling potential donors last week
- Journal of Clinical and Translational Science